| 产品编号 |
产品名称 |
序列 |
别称 |
CAS Number |
分子式 |
分子量 |
疾病类 |
包装 |
| 351248 |
N-[4-(-Carboxycyclohexylmethyl)]maleimide
|
|
|
64987-82-2 |
C12H15NO4 |
237.25 |
|
|
| 351249 |
2,5-dioxopyrrolidin-1-yl 1-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)phenyl)-1-oxo-5,8,11,14-tetraoxa-2-azahepta decan-17-oate
|
|
|
|
C26H31N3O11 |
561.54 |
|
|
| 3701-v |
FRETS-25Ala
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Ala-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3702-v |
FRETS-25Arg
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Arg-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3703-v |
FRETS-25Asn
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Asn-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3704-v |
FRETS-25Asp
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Asp-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3705-v |
FRETS-25Gln
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Gln-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3706-v |
FRETS-25Glu
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Glu-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3707-v |
FRETS-25Gly
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Gly-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3708-v |
FRETS-25His
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-His-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3709-v |
FRETS-25Ile
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Ile-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3710-v |
FRETS-25Leu
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Leu-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3711-v |
FRETS-25Lys
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Lys-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3712-v |
FRETS-25Met
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Met-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3713-v |
FRETS-25Phe
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Phe-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3714-v |
FRETS-25Pro
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Pro-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3715-v |
FRETS-25Ser
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Ser-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3716-v |
FRETS-25Thr
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Thr-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3717-v |
FRETS-25Trp
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Trp-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |
| 3718-v |
FRETS-25Tyr
|
序列
|
|
|
|
|
|
|
| D-A2pr(Nma)-Gly-[Phe/Ala/Val/Glu/Arg]-[Pro/Tyr/Lys/Ile/Asp]-Tyr-Ala-Phe-Pro-Lys(Dnp)-D-Arg-D-Arg A2pr(Nma):Nβ-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid |